Guided Therapeutics, Inc. (GTHP)
OTCMKTS · Delayed Price · Currency is USD
0.4800
0.00 (0.00%)
Jan 8, 2026, 4:00 PM EST
Guided Therapeutics Market Cap
Guided Therapeutics has a market cap or net worth of $41.35 million as of January 9, 2026. Its market cap has increased by 281.02% in one year.
Market Cap
41.35M
Enterprise Value
45.30M
Revenue
178.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.48
Market Cap Chart
Since July 1, 1997, Guided Therapeutics's market cap has decreased from 448.72M to 41.35M, a decrease of -90.78%. That is a compound annual growth rate of -8.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 41.26M | -11.11% |
| Dec 31, 2025 | 46.42M | 375.12% |
| Dec 31, 2024 | 9.77M | 17.63% |
| Dec 29, 2023 | 8.31M | -43.03% |
| Dec 30, 2022 | 14.58M | 84.30% |
| Dec 31, 2021 | 7.91M | 101.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 723.98M |
| Elite Pharmaceuticals | 503.78M |
| Northwest Biotherapeutics | 445.03M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 365.15M |
| Silence Therapeutics | 273.96M |